Ovarian/Bladder Cancer Flashcards
Carboplatin MOA
Forms DNA intrastrand crosslinks and adducts
Carboplatin Tox
Allergic platinum rxns; dose-related myelosuppression; cumulative anemia; dose-related N/V; Blood chemistry dyscrasia; elev hepatic enzymes, BUN/Cr
Carboplatin Use
Ovarian
Cisplatin MOA
Forms DNA intrastrand crosslinks and adducts
Cisplatin Tox
Allergic platinum rxns; dose-related severe nephrotox, myelosuppression, & N/V; significant ototox in children
Cisplatin Use
Ovarian + Bladder
Cyclophosphamide MOA
Pro-drug of active alkylating moiety
Cyclophosphamide Tox
Blood Dyscrasia: anemia/infxn; hemorrhagic cystitis (Mesna); N/V; rashes; amenorrhea/infertility; monitor for secondary malignancies; pulmonary fibrosis
Cyclophosphamide Use
Ovarian
Doxorubicin MOA
Intercalator, free radical generator, topo II inhibitor
Doxorubicin Tox
myelosuppression; CHF; hepatic dz; secondary malignancies; extravasational necrosis; N/V
Doxorubin Use
Ovarian + Bladder
Paclitaxel MOA
MT stabilizer inhibiting depolymerization
Paclitaxel Tox
Taxane hypersensitivity; myelosuppression; myalgia/arthralgia
Paclitaxel Use
Ovarian
BCG MOA
Binds to urothelial cells, activates APCs, induces prod of effector cells (CTL, NK, LAK, BAK)
BCG Use
Bladder; 50 mL instillation held for 1-2 hr weekly x6
Mitomycin C MOA
Mono- & bi-functional alkylating agent
MItomycin C Tox
Pancytopenia (when IV); chemical cystitis; contact dermatitis but also as palmar and plantar erythemas if contact made w/ instillate solution or void volume
Mytomycin C Use
Bladder
Thiotepa MOA
Polyfunctional alkylator with loss of aziridine (alkylator) moiety
Thiotepa Tox
Pancytopenia (when IV); dysuria; urinary retention; chemical/hemorrhagic cystitis; renal dysfxn
Thiotepa Use
Bladder